Inhibits angiogenesis by suppressing NF-κB activation and the subsequent production of angiogenic factors VEGF and IL-8 in vitro and in vivo of pancreatic cancer (BxPC-3). This evidence concerns the gene NFKB1 and familial pancreatic carcinoma.